Gallium-67 Scintigraphy in the Management: Hodgkin's Disease and Non-Hodgkin's Lymphoma
- 1 August 1999
- journal article
- review article
- Published by Mary Ann Liebert Inc in Cancer Biotherapy & Radiopharmaceuticals
- Vol. 14 (4) , 251-262
- https://doi.org/10.1089/cbr.1999.14.251
Abstract
Gallium scintigraphy has an important role in the management of patients with lymphoma. It contributes to patient management by detecting residual disease or relapse after treatment, monitoring response during therapy, and providing prognostic information.Keywords
This publication has 16 references indexed in Scilit:
- Revisiting the prognostic role of gallium scintigraphy in low-grade non-Hodgkin's lymphoma.European Journal of Nuclear Medicine and Molecular Imaging, 1997
- Bone LymphomaClinical Nuclear Medicine, 1996
- Ga-67 Scintigraphy in Pediatric PatientsClinical Nuclear Medicine, 1996
- Diffuse lung uptake of Ga-67 after treatment of lymphoma: is it of clinical importance?Radiology, 1996
- Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomasEuropean Journal of Nuclear Medicine and Molecular Imaging, 1995
- Role of magnetic resonance imaging in predicting relapse in residual masses after treatment of lymphoma.Journal of Clinical Oncology, 1993
- Lymphoma: predictive value of Ga-67 scintigraphy after treatment.Radiology, 1992
- Ga-67 SPECT before and after treatment of lymphoma.Radiology, 1990
- Planning mantle radiation therapy in patients with Hodgkin disease: role of gallium-67 scintigraphyAmerican Journal of Roentgenology, 1988
- Lymphoma: evaluation with Ga-67 SPECT.Radiology, 1987